Literature DB >> 1723667

Absorption of cytokines via oropharyngeal-associated lymphoid tissues. Does an unorthodox route improve the therapeutic index of interferon?

V Bocci1.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1723667     DOI: 10.2165/00003088-199121060-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  32 in total

Review 1.  Is interferon effective after oral administration? The state of the art.

Authors:  V Bocci
Journal:  J Biol Regul Homeost Agents       Date:  1990 Apr-Jun       Impact factor: 1.711

2.  Protection of mice from Semliki Forest virus infection by lymphocytes treated with low levels of interferon.

Authors:  G J Stanton; R E Lloyd; M Sarzotti; J E Blalock
Journal:  Mol Biother       Date:  1989

Review 3.  Central nervous system toxicity of interferons and other cytokines.

Authors:  V Bocci
Journal:  J Biol Regul Homeost Agents       Date:  1988 Jul-Sep       Impact factor: 1.711

4.  Development of animal recombinant DNA vaccine and its efficacy in foxes.

Authors:  M P Kieny; J Blancou; R Lathe; P P Pastoret; J P Soulebot; P Desmettre; J P Lecocq
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

5.  Interferon administered orally: protection of neonatal mice from lethal virus challenge.

Authors:  T W Schafer; M Lieberman; M Cohen; P E Came
Journal:  Science       Date:  1972-06-23       Impact factor: 47.728

6.  Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.

Authors:  H Yasui; E Proietti; F Vignaux; P Eid; I Gresser
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

7.  Oral use of human alpha interferon in cats.

Authors:  J M Cummins; M B Tompkins; R G Olsen; W A Tompkins; M G Lewis
Journal:  J Biol Response Mod       Date:  1988-10

8.  Chronic major aphthous stomatitis: oral treatment with low-dose alpha-interferon.

Authors:  V A Hutchinson; W L Mok; J L Angenend; J M Cummins; A B Richards
Journal:  Mol Biother       Date:  1990-12

9.  Interferon-gamma for the treatment of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responses.

Authors:  W Aulitzky; G Gastl; W E Aulitzky; K Nachbaur; B Lanske; G Kemmler; R Flener; J Frick; C Huber
Journal:  Immunobiology       Date:  1987-12       Impact factor: 3.144

10.  The motility of human milk macrophages in collagen gels.

Authors:  F Ozkaragöz; H B Rudloff; S Rajaraman; A A Mushtaha; F C Schmalstieg; A S Goldman
Journal:  Pediatr Res       Date:  1988-05       Impact factor: 3.756

View more
  6 in total

1.  Early administration of oropharyngeal colostrum to extremely low birth weight infants.

Authors:  Jonathan K Seigel; P Brian Smith; Patricia L Ashley; C Michael Cotten; Claudia C Herbert; Beth A King; Angela R Maynor; Sara Neill; James Wynn; Margarita Bidegain
Journal:  Breastfeed Med       Date:  2013-06-27       Impact factor: 1.817

2.  Oropharyngeal Colostrum for Preterm Infants: A Systematic Review and Meta-Analysis.

Authors:  Harshad Panchal; Gayatri Athalye-Jape; Sanjay Patole
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

3.  A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely low-birth-weight infants.

Authors:  Nancy A Rodriguez; Paula P Meier; Maureen W Groer; Janice M Zeller; Janet L Engstrom; Lou Fogg
Journal:  Adv Neonatal Care       Date:  2010-08       Impact factor: 1.968

Review 4.  Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives.

Authors:  N A Rodriguez; P P Meier; M W Groer; J M Zeller
Journal:  J Perinatol       Date:  2008-09-04       Impact factor: 2.521

5.  Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.

Authors:  Staley A Brod
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-14

6.  Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial.

Authors:  Nancy A Rodriguez; Maximo Vento; Erika C Claud; Chihsiung E Wang; Michael S Caplan
Journal:  Trials       Date:  2015-10-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.